Sector: Healthcare|Industry: Biotechnology|Market Cap: $119.42B|Employees: 5.4K
Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on developing and commercializing transformative medicines for people with serious diseases, primarily in specialty markets. The company's main revenue streams come from sales of its cystic fibrosis and sickle cell disease therapies, which treat the underlying causes of these diseases. Vertex holds a leading market position in cystic fibrosis and has a strong pipeline of clinical-stage programs in various therapeutic areas.
Detailed Profile